« Return to News | Technology Solutions

Instem enters early phase market

Friday, June 21, 2013 03:13 PM

Instem of Conshohocken, Pa., a provider of IT solutions to the global early development healthcare market, has entered the early phase clinical trials market with its recent acquisition of Logos Technologies.

The latest release of the ALPHADAS software solution suite is a proactive eSource clinical trials system that is mobile, schedule-driven and provides real-time bedside or station-based direct data capture that virtually eliminates paper-based data. ALPHADAS delivers quality, operational efficiencies and time savings across the clinic, data management, recruitment, site administration and the laboratory.

The new system enhances Instem’s Study Workflow and Automation Suite that enables organizations of all sizes to collect, manage, review and submit study data that streamline processes, increase quality and enhance development programs.

Instem’s entry into the early clinical market provides greater access to early phase clinical data in both healthy and patient populations, advancing Instem’s translational informatics technology strategy. Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem has full offices in the U.S., the U.K. and China, with additional locations in India and a full-service distributor based in Japan.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.